Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes
- PMID: 14973079
- DOI: 10.1158/0008-5472.can-03-3214
Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes
Abstract
Whereas two key steps in cervical carcinogenesis are integration of high-risk human papillomavirus (HR-HPV) and acquisition of an unstable host genome, the temporal association between these events is poorly understood. Chromosomal instability is induced when HR-HPV E7 oncoprotein is overexpressed from heterologous promoters in vitro. However, it is not known whether such events occur at the "physiologically" elevated levels of E7 produced by deregulation of the homologous HR-HPV promoter after integration. Indeed, an alternative possibility is that integration in vivo is favored in an already unstable host genome. We have addressed these issues using the unique human papillomavirus (HPV) 16-containing cervical keratinocyte cell line W12, which was derived from a low-grade squamous intraepithelial lesion and thus acquired HPV16 by "natural" infection. Whereas W12 at low passage contains HPV16 episomes only, long-term culture results in the emergence of cells containing integrated HPV16 only. We show that integration of HPV16 in W12 is associated with 3' deletion of the E2 transcriptional repressor, resulting in deregulation of the homologous promoter of the integrant and an increase in E7 protein levels. We further demonstrate that high-level chromosomal instability develops in W12 only after integration and that the forms of instability observed correlate with the physical state of HPV16 DNA and the level of E7 protein. Whereas intermediate E7 levels are associated with numerical chromosomal abnormalities, maximal levels are associated with both numerical and structural aberrations. HR-HPV integration is likely to be a critical event in cervical carcinogenesis, preceding the development of chromosomal abnormalities that drive malignant progression.
Similar articles
-
Virus transcript levels and cell growth rates after naturally occurring HPV16 integration events in basal cervical keratinocytes.J Pathol. 2014 Jul;233(3):281-93. doi: 10.1002/path.4358. Epub 2014 May 21. J Pathol. 2014. PMID: 24752734 Free PMC article.
-
Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3822-7. doi: 10.1073/pnas.0600078103. Epub 2006 Feb 27. Proc Natl Acad Sci U S A. 2006. PMID: 16505361 Free PMC article.
-
Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.Cancer Res. 2002 Dec 1;62(23):6959-65. Cancer Res. 2002. PMID: 12460913
-
Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?J Pathol. 2007 Aug;212(4):356-67. doi: 10.1002/path.2192. J Pathol. 2007. PMID: 17573670 Review.
-
The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.Cytokine Growth Factor Rev. 2017 Apr;34:1-13. doi: 10.1016/j.cytogfr.2017.03.002. Epub 2017 Mar 23. Cytokine Growth Factor Rev. 2017. PMID: 28365229 Review.
Cited by
-
Human papillomavirus DNA and oncogene alterations in colorectal tumors.Pathol Oncol Res. 2010 Sep;16(3):461-8. doi: 10.1007/s12253-010-9246-x. Epub 2010 Mar 17. Pathol Oncol Res. 2010. PMID: 20232185
-
Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.J Virol. 2011 Feb;85(4):1645-54. doi: 10.1128/JVI.02093-10. Epub 2010 Dec 1. J Virol. 2011. PMID: 21123375 Free PMC article.
-
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.Lancet. 2015 Nov 21;386(10008):2078-2088. doi: 10.1016/S0140-6736(15)00239-1. Epub 2015 Sep 17. Lancet. 2015. PMID: 26386540 Free PMC article. Clinical Trial.
-
ATM Pathway Is Essential for HPV-Positive Human Cervical Cancer-Derived Cell Lines Viability and Proliferation.Pathogens. 2022 Jun 1;11(6):637. doi: 10.3390/pathogens11060637. Pathogens. 2022. PMID: 35745491 Free PMC article.
-
Virus transcript levels and cell growth rates after naturally occurring HPV16 integration events in basal cervical keratinocytes.J Pathol. 2014 Jul;233(3):281-93. doi: 10.1002/path.4358. Epub 2014 May 21. J Pathol. 2014. PMID: 24752734 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources